GENFIT
GENFIT, a biopharmaceutical company headquartered in France, is at the forefront of developing innovative therapies for metabolic and liver diseases. Founded in 2008, the company has made significant strides in the industry, particularly with its focus on non-alcoholic steatohepatitis (NASH) and other related conditions. With a robust pipeline of clinical programmes, GENFIT's core products, including its lead candidate elafibranor, are designed to address unmet medical needs in liver health. The company distinguishes itself through its commitment to precision medicine and the integration of advanced biomarkers in its research. Recognised for its expertise, GENFIT has established a strong market position, contributing to the evolving landscape of liver disease treatment. Its dedication to innovation and patient-centric solutions continues to drive its success in the biopharmaceutical sector.
DitchCarbon Score
How does GENFIT's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GENFIT's score of 39 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GENFIT's reported carbon emissions
In 2023, GENFIT reported total carbon emissions of approximately 663,000 kg CO2e from Scope 1, 92,000 kg CO2e from Scope 2, and 804,000 kg CO2e from Scope 3 emissions. This reflects a commitment to transparency in their environmental impact, although specific reduction targets or initiatives have not been disclosed. In 2022, the company recorded emissions of about 700,000 kg CO2e for Scope 1, 101,000 kg CO2e for Scope 2, and 776,000 kg CO2e for Scope 3. The previous year, 2021, saw emissions of approximately 746,000 kg CO2e from Scope 1, 100,000 kg CO2e from Scope 2, and 751,000 kg CO2e from Scope 3. Despite the lack of formal reduction targets or climate pledges, GENFIT's emissions data indicates a focus on monitoring and reporting their carbon footprint, aligning with industry standards for climate accountability. The company continues to operate from its headquarters in France, contributing to global efforts in reducing carbon emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 627,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 110,000 | 000,000 | 000,000 | 00,000 |
| Scope 3 | - | 000,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GENFIT is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
